Account
iCubesWire bags Printronix digital mandate
MUMBAI: The race for pocketing companies’ digital mandates in India is getting intense. Digital advertising is one of the fastest expanding mediums at a CAGR of 33.5 per cent (2015-2020) with expectations of crossing Rs 255 billion in 2020.
iCubesWire, a digital marketing solution and concept provider, has won the digital media duties of Printronix. It addresses the needs for mission-critical industrial printing.
The responsibilities include managing digital media as well as the creative mandate for Printronix. It is one of the biggest accounts won by iCubesWire, and the team will be responsible for increasing its brand awareness and digital growth.
iCubesWire CEO Sahil Chopra says, “We will strive to impart equally innovative strategies and solutions to enhance the brand connect.”
Printronix country director – India and South Asia Anand Kumar says, “After getting acquainted with their farsighted vision, we are confident that iCubesWire’s team will work with the best of their abilities and help elevate our brand presence digitally.”
According to KPMG and CII’s combined study, India is one of the fastest growing advertising markets globally with a large consumer base and a burgeoning e-commerce industry.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
